Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
06/2004
06/03/2004US20040106619 For prevention and/or treatment for HIV infection or AIDS induced by the infection
06/03/2004US20040106618 3-heteroarylidene-2-indolinone compounds useful in the prevention and treatment of protein kinase related cellular disorders such as cancer
06/03/2004US20040106616 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity
06/03/2004US20040106608 Novel imidazole compounds as transforming growth factor (TGF) inhibitors
06/03/2004US20040106604 Novel pyrrole derivatives as pharmaceutical agents
06/03/2004US20040106597 Novel fused indazoles and indoles and their use for the treatment of glaucoma
06/03/2004US20040106596 Pyridoquinoxaline antivirals
06/03/2004US20040106574 4-substituted with a imidazo[1,2a]pyrid-3-yl or pyrazolo[2,3a]pyrid-3-yl ring
06/03/2004US20040106124 Identifying genotype for depressive episodes and modifying administration of antidepressants and adrenergic stimulants
06/03/2004DE10254092A1 New pyrimidine-4,6-dicarboxamide derivatives, are selective collagenase inhibitors useful e.g. for treating degenerative joint diseases, connective tissue disorders or cancer
06/03/2004CA2506316A1 Substituted indolepyridinium as anti-infective compounds
06/03/2004CA2506027A1 8-substituted imidazopyridines
06/03/2004CA2506025A1 Amino-heterocycles as vr-1 antagonists for treating pain
06/03/2004CA2506010A1 A method for deuteration of a heterocyclic ring
06/03/2004CA2505789A1 Diaminotriazoles useful as inhibitors of protein kinases
06/03/2004CA2505752A1 Imidazo[1,5a]pyridine derivatives and methods for treating aldosterone mediated diseases
06/02/2004EP1424326A1 Fused-polycyclic compounds
06/02/2004EP1423393A1 Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments
06/02/2004EP1423390A2 Purine inhibitors of phosphodiesterase (pde) 7
06/02/2004EP1423389A1 Pyrazolo-pyridines for the treatment of herpes infections
06/02/2004EP1423388A2 2-arylamino-pyrimidines for the treatment of gsk3-related disorders
06/02/2004EP1423123A1 Tetracyclic indole derivatives as 5-ht receptor ligands
06/02/2004EP1423120A1 2h-phthalazin-1-ones and methods for use thereof
06/02/2004EP1423119A1 Heterobicycles fkbp-ligands
06/02/2004EP1423006A1 Agonists and antagonists of 5h 3?-like receptors of invertebrate s as pesticides
06/02/2004EP1326613B1 Use of substituted imidazo 1,2-a]pyridine-, imidazo [1,2-a]pyrimidine and imidazo [1,2-a]pyrazine-3-yl-amine derivatives for producing nos-inhibiting medicaments
06/02/2004EP1259510B1 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
06/02/2004EP1204662B1 Azaindoles having serotonin receptor affinity
06/02/2004EP0769966B1 Biotin compounds for targetting tumors and sites of infection
06/02/2004CN1501937A Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
06/02/2004CN1501931A Novel tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
06/02/2004CN1501930A Novel pyridine- and cyclohexenyl-comprising pyrrolobenzodiazepi ne-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists
06/02/2004CN1501926A Mercaptoacetylamide derivatives, process for their preparation and use thereof
06/02/2004CN1501813A Visual function improving agents
06/02/2004CN1500785A Sophora flavescens alkaloid and production technology thereof
06/02/2004CN1152049C Treatment of insulin resistance with growth hormone secretagogues
06/02/2004CN1152022C Alpha-substituted. pyrimidine-thioalkyl and alkyl ether compounds
06/02/2004CN1152021C Intermediate for preparing corticotropin release factors antagonistic agent and preparing method thereof
06/02/2004CN1152014C N-aryl anthranilic acid derivatives and uses thereof
06/01/2004USRE38524 Dipeptide derivatives as growth hormone secretagogues
06/01/2004US6743920 Chorination replacing hydroxyl groups of 2,4-dihyroxy-3-nitropyridine derivative; amination, hydroxyarylation, reduction and cyclization; amine replacement of phenoxy functionality
06/01/2004US6743919 2-aroylimidazole compounds for treating cancer
06/01/2004US6743917 Camptothecin analogs and methods of preparation thereof
06/01/2004US6743877 Electrode materials derived from polyquinonic ionic compounds and their use in electrochemical generators
06/01/2004US6743803 Medicines for the prevention and treatment of neurodegenerative diseases
06/01/2004US6743802 Alkyne-aryl phosphodiesterase-4 inhibitors
06/01/2004US6743798 Cardiovascular disorders; vasorelaxation, inhibition of platelet aggregation, decrease in blood pressure; stimulation of soluble guanylate cyclase and an intracellular cgmp increase
06/01/2004US6743794 Methods and compounds for inhibiting MRP1
06/01/2004US6743786 Vanadium compounds for treating cancer
06/01/2004US6743415 Delivery of anti-migraine compounds through an inhalation route
05/2004
05/27/2004WO2004043967A1 Spirocyclic cyclohexane derivatives
05/27/2004WO2004043966A1 New tricyclic derivatives as ltd4 antagonists
05/27/2004WO2004043960A1 1,4-diazabicyclo (3,2,2)nonane derivatives, preparation and therapeutical use thereof
05/27/2004WO2004043959A1 Novel parp inhibitors
05/27/2004WO2004043958A1 Fused heterocyclic compounds
05/27/2004WO2004043957A1 Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same
05/27/2004WO2004043956A1 Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
05/27/2004WO2004043950A1 Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
05/27/2004WO2004043940A1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
05/27/2004WO2004043931A1 Propanamine derivatives as serotonin and norepinephrine reuptake inhibitors
05/27/2004WO2004043925A2 3-substituted-6-aryl pyridined as ligands of c5a receptors
05/27/2004WO2004043923A1 Process for making risperidone and intermediates therefor
05/27/2004WO2004043913A2 Hetero-substituted benzimidazole compounds and antiviral uses thereof
05/27/2004WO2004043458A1 Bicyclic-substituted amines as histamine-3 receptor ligands
05/27/2004WO2004043389A2 Methods of treating cancer and related methods
05/27/2004WO2004043367A2 Fused heterocyclic compounds and use thereof
05/27/2004WO2004043337A2 Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
05/27/2004WO2004018465A3 Benzonaphthyridines with pde 3/4 inhibiting activity
05/27/2004WO2003039549A3 Selective antibacterial agents
05/27/2004WO2003031436A8 Heterocyclic compounds for use in the treatment of disorders of the urinary tract
05/27/2004WO2002065977A8 Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof
05/27/2004US20040102510 Cancer; the compounds interact with the amino acids in the catalytic region of PKs and bind in the general space normally occupied by the adenine ring of ATP
05/27/2004US20040102506 Pyrazole compositions useful as inhibitors of ERK
05/27/2004US20040102497 Novel inhibitors of IMPDH enzyme
05/27/2004US20040102472 Method of preparing inhibitors of phosphodiesterase-4
05/27/2004US20040102471 Viricides; anticancer agents
05/27/2004US20040102467 Antiinflammatory agents; central nervous system disorders; antiproliferative agents
05/27/2004US20040102450 Substituted oxoazaheterocyclyl compounds
05/27/2004US20040102443 Nitro and amino substituted topoisomerase agents
05/27/2004US20040102442 Central nervous system disorders; brain disorders
05/27/2004US20040102432 Asthma, rhinitis therapy
05/27/2004DE10252667A1 New spiro-((cyclohexane)-tetrahydropyrano-(3,4-b)-indole) derivatives, are ORL1 receptor ligands useful e.g. for treating anxiety, depression, epilepsy, senile dementia, withdrawal symptoms or especially pain
05/27/2004CA2765093A1 Bicyclic-substituted amines as histamine-3 receptor ligands
05/27/2004CA2505876A1 Novel parp inhibitors
05/27/2004CA2505819A1 Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
05/27/2004CA2505491A1 New tricyclic derivatives as ltd4 antagonists
05/27/2004CA2505372A1 Fused heterocyclic compounds
05/27/2004CA2504008A1 Novel imidazopyridine derivatives, process for their preparation and pharmaceutical compositions containing them
05/27/2004CA2503995A1 Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
05/27/2004CA2501932A1 Use of benzimidazole quinolinones for treating cancer
05/26/2004EP1421087A1 Diazacycloalkanes as oxytocin agonists
05/26/2004EP1421083A1 Novel imidazopyridine compounds with therapeutic effect
05/26/2004EP1420785A2 SUBSTITUTED INDENO 1,2-c]ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF
05/26/2004EP1117642B1 Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use
05/26/2004EP1027332B1 Novel lactam metalloprotease inhibitors
05/26/2004EP1023291B1 Dipyridoimidazolderivatives useful in treating central nervous system disorders
05/26/2004EP1022272B1 Substituted fused heterocyclic compounds
05/26/2004EP1015433B1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments
05/26/2004EP1005445B1 N-alkanoylphenylalanine derivatives
05/26/2004CN1500090A Beta-carboline derivatives and its pharmaceutical use against depression and anxiety